See All Slides - tctmd.com

Slides

Presentation TCT 2019

TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

Presenter: Usman Baber

September 26, 2019

Presentation TCT 2019

AUGUSTUS ACS: A 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation and an Acute Coronary Syndrome

Presenter: Stephan Windecker

September 26, 2019

Presentation TCT 2019

MODEL U-SES: A Single-Arm Study of 3-Month DAPT in Patients Treated With a Bioabsorbable Polymer-Based Sirolimus-Eluting Stent

Presenter: Ken Kozuma

September 26, 2019

Presentation TCT 2019

EVOLVE Short DAPT: A Single-Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable Polymer-Based Everolimus-Eluting Stent

Presenter: Ajay Kirtane

September 26, 2019

Presentation TCT 2019

The Future in Managing Patients at High Bleeding Risk

Presenter: Elvin Kedhi

September 26, 2019

Presentation TCT 2019

Case-Based Discussion: Rely on Simplicity for Complex PCI with Second-Generation Fiber-Optic

Presenter: Evan Shlofmitz

September 26, 2019

Presentation TCT 2019

Other Transcatheter Approaches to TR Reduction: Spacer, Leaflet Grasping, and Tricuspid Valve Replacement

Presenter: Susheel Kodali

September 26, 2019

Presentation TCT 2019

Two Case Presentations Highlighting Relevant Patients

Presenter: David Kandzari

September 26, 2019

Presentation TCT 2019

Coronary Physiology: From Diagnosis to Treatment Confirmation

Presenter: Barry Uretsky

September 26, 2019

Presentation TCT 2019

Annular Reduction and 3D ICE

Presenter: Charles Davidson

September 26, 2019

Advertisement

Slides

TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

AUGUSTUS ACS: A 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation and an Acute Coronary Syndrome

MODEL U-SES: A Single-Arm Study of 3-Month DAPT in Patients Treated With a Bioabsorbable Polymer-Based Sirolimus-Eluting Stent

EVOLVE Short DAPT: A Single-Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable Polymer-Based Everolimus-Eluting Stent

The Future in Managing Patients at High Bleeding Risk

Case-Based Discussion: Rely on Simplicity for Complex PCI with Second-Generation Fiber-Optic

Other Transcatheter Approaches to TR Reduction: Spacer, Leaflet Grasping, and Tricuspid Valve Replacement

Two Case Presentations Highlighting Relevant Patients

Coronary Physiology: From Diagnosis to Treatment Confirmation

Annular Reduction and 3D ICE

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content